Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06388135
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-29
First Post:
2024-04-18
Brief Title:
Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Sponsor:
Yang Jianjun PhD
Organization:
Xijing Hospital
Organization Data
Organization:
Xijing Hospital
Class:
OTHER
Study ID:
SNC-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yang Jianjun PhD
Lead Sponsor Class:
OTHER
Responsible Party:
Yang Jianjun PhD
Responsible Party Title:
Professor from Xijing Hospital
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Xijing Hospital
Old Name:
None
Old Organization:
None